UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________
FORM 8-K
________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 28, 2024
________________________________________
Schrodinger, Inc.
(Exact name of Registrant as Specified in Its Charter)
________________________________________
| | | | | | | | |
| Delaware | 001-39206 | 95-4284541 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| (Commission File Number) |
| | |
1540 Broadway, 24th Floor New York, NY | | 10036 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (212) 295-5800
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | |
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of each class | | Trading
Symbol(s) | | Name of each exchange on which registered |
| Common stock, par value $0.01 per share | | SDGR | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 1.01 Entry into a Material Definitive Agreement.
On February 28, 2024, Schrödinger, Inc., a Delaware corporation (the “Company”), entered into an Amended and Restated Sales Agreement (the “Sales Agreement”) with Leerink Partners LLC, as agent (“Leerink Partners”), pursuant to which the Company may offer and sell shares of its common stock, $0.01 par value per share (the “Common Stock”), from time to time through Leerink Partners. The shares of Common Stock to be sold under the Sales Agreement (the “Shares”), if any, may be issued and sold pursuant to the Company’s shelf Registration Statement on Form S-3ASR (File No. 333-277479), which became automatically effective upon filing on February 28, 2024 (the “Registration Statement”), and a prospectus, dated February 28, 2024, relating to the Shares, which forms a part of the Registration Statement (the “Prospectus”). Pursuant to the Prospectus, the Company may offer and sell Shares through Leerink Partners having an aggregate offering price of up to $250.0 million under the Sales Agreement. The Sales Agreement amends and restates the sales agreement the Company previously entered into with Leerink Partners on May 24, 2023 (the “Prior Sales Agreement”), which is no longer in effect. The Company did not sell any shares of its Common Stock under the Prior Sales Agreement.
Upon delivery of a placement notice and subject to the terms and conditions of the Sales Agreement, Leerink Partners may sell the Shares by any method permitted that is deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended.
The Company or Leerink Partners may suspend or terminate the offering of the Shares upon notice to the other party, subject to certain conditions. Leerink Partners will act as sales agent using commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq Global Select Market.
The Company has agreed to pay Leerink Partners commissions for its services as agent of up to 3.0% of the aggregate gross proceeds from the sale of the Shares pursuant to the Sales Agreement. The Company has also agreed to provide Leerink Partners with customary indemnification and contribution rights.
The foregoing description of the Sales Agreement is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is filed as Exhibit 1.1 hereto and incorporated herein by reference.
This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the Shares, nor shall there be any sale of the Shares in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities law of such state or jurisdiction.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits:
| | | | | | | | |
Exhibit Number | | Description |
| 1.1 | | |
| 104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | |
| Schrödinger, Inc. |
| | |
| Date: February 28, 2024 | By: | /s/ Yvonne Tran |
| | Yvonne Tran |
| | Chief Legal Officer and Corporate Secretary |
